<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33539">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02009319</url>
  </required_header>
  <id_info>
    <org_study_id>ENDO - 004</org_study_id>
    <nct_id>NCT02009319</nct_id>
  </id_info>
  <brief_title>Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients</brief_title>
  <official_title>Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University Clinic of Pulmonary and Allergic Diseases Golnik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University Clinic of Pulmonary and Allergic Diseases Golnik</source>
  <oversight_info>
    <authority>Slovenia: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this pilot study is to evaluate EBUS elastography strain ratio in assessment of
      mediastinal lymph nodes in patients with suspicion for lung cancer for the first time.
      Strain ratios of mediastinal lymph nodes will be compared with EBUS B-mode features and with
      tissue diagnosis as a gold standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation will be performed on consenting consecutive patients at least 18 years old,
      referred to bronchoscopy with suspicion for lung cancer according to chest CT-scan. Eligible
      patients should have either enlarged discrete N2/N3 lymph nodes, or central tumor or
      enlarged N1 lymph nodes with normal mediastinal lymph nodes. Exclusion criteria will be
      metastatic disease, severe co-morbidity that disqualified surgical treatment, mediastinal
      infiltration by tumor and small peripheral lung tumor with normal-sized mediastinal lymph
      nodes.

      Outcomes: Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative
      predictive value (NPV) for probability of malignant lymph node diagnosis, determined by
      elastography strain ratio. Receiver operating characteristic (ROC) analysis will be made to
      display specificity / sensitivity for different strain ratio cut-off values. Area under the
      ROC curve will be calculated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>elastography strain ratio</measure>
    <time_frame>up to 7 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Lung Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EBUS TBNA lymph node specimen - a part of routine diagnostic procedure
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients at least 18 years old, referred to bronchoscopy with suspicion for
        lung cancer according to chest CT-scan
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  enlarged discrete N2/N3 lymph nodes

          -  central tumor with normal mediastinal lymph nodes

          -  enlarged N1 lymph nodes with normal mediastinal lymph nodes

        Exclusion Criteria:

          -  metastatic disease

          -  severe co-morbidity that disqualified surgical treatment

          -  mediastinal infiltration by tumor

          -  small peripheral lung tumor with normal-sized mediastinal lymph nodes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ales Rozman, MD, specialist</last_name>
    <phone>+38641313811</phone>
    <email>ales.rozman@klinika-golnik.si</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mateja Marc, PhD, specialist</last_name>
    <phone>+38642569172</phone>
    <email>mateja.marc@klinika-golnik.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinic of Pulmonary and Allergic Diseases Golnik</name>
      <address>
        <city>Golnik</city>
        <zip>4204</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ales Rozman, MD, specialist</last_name>
      <phone>+39641313811</phone>
      <email>ales.rozman@klinika-golnik.si</email>
    </contact>
    <investigator>
      <last_name>Ales Rozman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mateja Marc, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 8, 2013</lastchanged_date>
  <firstreceived_date>December 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University Clinic of Pulmonary and Allergic Diseases Golnik</investigator_affiliation>
    <investigator_full_name>Ale≈° Rozman</investigator_full_name>
    <investigator_title>MD, specialist from pulmonary diseases</investigator_title>
  </responsible_party>
  <keyword>endobronchial ultrasound</keyword>
  <keyword>EBUS - TBNA</keyword>
  <keyword>elastography</keyword>
  <keyword>strain ratio</keyword>
  <keyword>lung cancer staging</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
